Keyword: United Kingdom

Blueberry Therapeutics raised £10 million in series B funding that will advance a nanomedicine for athlete's foot and a fungal nail infection.

U.K.-based CRO Sygnature Discovery unveiled plans to expand the footprint of its campus with the addition of a new facility.

A trio of aging-focused biotechs and research firms formed a joint venture to develop small molecules for a novel target hoping to extend life spans.

GN Hearing unveiled the first in a new category of its ReSound LiNX 3D line of hearing aids, which it dubs as “premium-plus,” at a higher price point.

Brand-new U.K. biotech Izana has kicked off a phase 2a trial of anti-GM-CSF antibody namilumab in ankylosing spondylitis.

Sensyne Health plans to go public with a £60 million listing ($77 million) on the London Stock Exchange on Aug. 17.

Officials reiterated their intent for the U.K. to implement the incoming EU Clinical Trials Regulation and expanded on the long-term effect of Brexit.

A startup called Macregen has licensed an eye drop that can penetrate the cells of the retina and deliver a treatment for AMD.

The voted-for text tasks the government with seeking to secure the right for the U.K. to “fully participate” in the EMA after Brexit.

Biotech news over the last week included insight into a protein that powers the flu and an immune-boosting treatment for prostate cancer.